European Journal of Internal Medicine

Papers
(The H4-Index of European Journal of Internal Medicine is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Electrocardiographic changes associated with hypothermia224
Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients205
Non-pharmacological home remedies used by primary care patients153
Effects of the implementation of the dynamic silver code in the emergency department136
The role of age in recognizing cognitive impairment in the emergency department124
Telemedicine in internal medicine: A statement by the European Federation of Internal Medicine.120
Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?96
A woman with purple-brown skin lesions after immunosuppressive therapy87
Health differences between adults with and without intellectual disabilities at the internal medicine department: A first step to improve awareness of intellectual disabilities among healthcare profes77
The higher the serum albumin, the better? Findings from the PRACTICE study74
Abdominal aortic aneurysm and gas in the kidney in a diabetes patient70
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines68
Internists or specialists-that is the question!68
No evidence of a “July Effect” on mortality65
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus63
The peculiarities of COVID-19 in older people: Considerations after two years59
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation59
How the theory of centralized aerobic-anaerobic energy balance compensation explains sudden cardiac death in young athletes52
Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality52
Effects of statins on clinical outcomes in hospitalized patients with COVID-1951
Aspirin and P2Y12 inhibitors in treating COVID-1945
Heart failure: An autopsy case44
Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease44
Natural history of ‘silent’ atrial fibrillation from subclinical to asymptomatic: State of the art and need for research42
Optimal duration of anticoagulation therapy for venous thromboembolism in autoimmune diseases40
Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age39
Recurrent vomiting38
Clinical characteristics of BRASH syndrome: Systematic scoping review37
A man with brown macules on the limbs37
Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)35
Refining metabolic health assessment in inflammatory bowel disease risk prediction35
Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA35
Prognostic impact of hypertension grading34
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease34
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients34
0.1156530380249